-
Kelun, Merck tout ADC as potential first-line treatment in lung cancer
26 Nov 2025 04:39 GMT
… breast cancer in China. Merck holds rights to the TROP2 … a broader effort by the pharmaceutical giant to develop new … patent protection this decade.
Merck is currently testing the candidate … be a narrative shift for Merck,” Jefferies analyst Akash Tewari …
-
Merck Sharp & Dohme discovers new GTPase KRAS inhibitors
25 Nov 2025 07:44 GMT
-
<![CDATA[Pharmaceutical Executive Daily: Tesaro and AnaptysBio's Legal Battle]]>
25 Nov 2025 04:24 GMT
… industry.
In today’s Pharmaceutical Executive Daily, learn … Valo is partnering with Merck KGaA to pursue small- … And in distribution strategy, pharmaceutical companies are increasingly building …
Thanks for listening to Pharmaceutical Executive Daily. For more …
-
Pharmaceutical Filtration Market Projected to Witness a Growth of US $9.49 Bn by 2029 | The Business Research Company
25 Nov 2025 00:15 GMT
… Technologies LLC
• Meissner Filtration Products
• Merck & Co. Inc.
• Parker Bioscience … .thebusinessresearchcompany.com/report/pharmaceutical-contract-developments-and-manufacturing-organization …
-
Pharmaceutical Filtration Market Projected to Witness a Growth of US $9.49 Bn by 2029 | The Business Research Company
24 Nov 2025 00:15 GMT
… Technologies LLC
• Meissner Filtration Products
• Merck & Co. Inc.
• Parker Bioscience … .thebusinessresearchcompany.com/report/pharmaceutical-contract-developments-and-manufacturing-organization …
-
Merck bags European Commission nod for subcutaneous administration of Keytruda for all adult indications approved in EU
23 Nov 2025 10:16 GMT
Rahway: Merck, known as MSD outside of … a new pharmaceutical form (solution for injection) of KEYTRUDA (pembrolizumab), Merck’s … of oncology, global clinical development, Merck Research Laboratories. “We are committed …
-
Sudeep Pharma IPO Review by Hem Securities; India's Burgeoning Pharmaceutical Excipients Ecosystem Offers Strong Growth Opportunity
22 Nov 2025 21:14 GMT
… names including Pfizer Inc., Merck Group, Intas Pharmaceuticals Limited, and Aurobindo Pharma … relationships encompass Pfizer Inc., Merck Group, Intas Pharmaceuticals Limited, Mankind Pharma Limited …
-
Merck Recommends Rejection of Tutanota’s “Mini-Tender” Offer
22 Nov 2025 08:28 GMT
… s mini-tender offer.
Merck shareholders who have already … offer dissemination and disclosure.
Merck requests that a copy … shares of Merck common stock.
About Merck
At Merck, known as … fluctuations; the impact of pharmaceutical industry regulation and health …
-
Merck’s Two-Drug HIV Regimen Meets Phase 3 Trial Goals
21 Nov 2025 16:16 GMT
Merck announced positive topline results from a pivotal Phase 3 trial evaluating its once-daily, oral two-drug regimen doravirine/islatravir (DOR/ISL) in treatment-naïve adults with HIV-1. The regimen met the primary efficacy endpoint, …
-
Ethical Pharmaceuticals Market Projected to Reach $13.05 Billion with 13.2% CAGR by 2029
21 Nov 2025 09:30 GMT
…
• GlaxoSmithKline PLC
• Teva Pharmaceutical Industries Ltd.
• Merck & Co. Inc.
… Healthcare, another Indian pharmaceutical entity, collectively initiated the … 47;generic-pharmaceuticals-global-market-report
Veterinary Pharmaceuticals Global Market …
About
© 1995-2025